Highline Capital Management, L.P. / RARE
Highline Capital Management, L.P.’s Ultragenyx Pharmaceutical In Position
Does Highline Capital Management, L.P. own Ultragenyx Pharmaceutical In (RARE)? Not currently — the last reported position was 295.7K shares worth $13M in Q3 2019; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$13M
Q3 2019
Shares
295.7K
% of Portfolio
+1.85%
Quarters Held
3
position exited
Position History RARE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highline Capital Management, L.P.’s full portfolio or all institutional holders of RARE.